[HTML][HTML] Robust and durable serological response following pediatric SARS-CoV-2 infection

…, P Frieh, A Haddad, T Görne, J Remppis… - Nature …, 2022 - nature.com
The quality and persistence of children’s humoral immune response following SARS-CoV-2
infection remains largely unknown but will be crucial to guide pediatric SARS-CoV-2 …

[HTML][HTML] Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational …

…, T Stamminger, SFN Bode, T Himpel, J Remppis… - …, 2022 - thelancet.com
Background Long COVID in children and adolescents remains poorly understood due to a
lack of well-controlled studies with long-term follow-up. In particular, the impact of the family …

[HTML][HTML] Transmission of severe acute respiratory syndrome coronavirus 2 in households with children, southwest Germany, May–August 2020

…, N Ruetalo, A Peter, J Remppis… - Emerging Infectious …, 2021 - ncbi.nlm.nih.gov
Resolving the role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
transmission in households with members from different generations is crucial for containing the …

Efficacy and safety of fosmidomycin–piperaquine as nonartemisinin-based combination therapy for uncomplicated falciparum malaria: A single-arm, age de-escalation …

G Mombo-Ngoma, J Remppis, M Sievers… - Clinical Infectious …, 2018 - academic.oup.com
Background Fosmidomycin–piperaquine is being developed as nonartemisinin-based
combination therapy to meet the challenge of emerging artemisinin resistance. Methods The …

[HTML][HTML] A case series of children and young people admitted to a tertiary care hospital in Germany with COVID-19

J Remppis, T Ganzenmueller… - BMC Infectious …, 2021 - Springer
Background While our knowledge about COVID-19 in adults has rapidly increased, data on
the course of disease and outcome in children with different comorbidities is still limited. …

Antibody binding and angiotensin-converting enzyme 2 binding inhibition Is significantly reduced for both the BA. 1 and BA. 2 Omicron variants

…, S Göpel, M Bitzer, H Renk, J Remppis… - Clinical Infectious …, 2023 - academic.oup.com
Background The rapid emergence of the Omicron variant and its large number of mutations
led to its classification as a variant of concern (VOC) by the World Health Organization. …

Typically asymptomatic but with robust antibody formation: Children's unique humoral immune response to SARS-CoV-2

…, L Fritsch, P Frieh, A Haddad, T Görne, J Remppis… - medRxiv, 2021 - medrxiv.org
Background Long-term persistence of antibodies against SARS-CoV-2, particularly the
SARS-CoV-2 Spike Trimer, determines individual protection against infection and potentially viral …

[HTML][HTML] Tuberculosis treatment outcome and drug resistance in Lambaréné, Gabon: a prospective cohort study

S Bélard, J Remppis, S Bootsma… - The American journal …, 2016 - ncbi.nlm.nih.gov
Despite overall global progress in tuberculosis (TB) control, TB remains one of the deadliest
communicable diseases. This study prospectively assessed TB epidemiology in Lambaréné…

Prospective clinical trial assessing species-specific efficacy of artemether-lumefantrine for the treatment of Plasmodium malariae, Plasmodium ovale, and mixed …

…, J Kim, T Nguyen, L Flohr, J Remppis… - Antimicrobial agents …, 2018 - Am Soc Microbiol
ABSTRACT Treatment recommendations for Plasmodium malariae and Plasmodium ovale
malaria are largely based on anecdotal evidence. The aim of this prospective study, …

[HTML][HTML] Role of ABO blood group in SARS-CoV-2 infection in households

A Janda, C Engel, J Remppis, S Enkel, A Peter… - Frontiers in …, 2022 - frontiersin.org
An association between certain ABO/Rh blood groups and susceptibility to SARS-CoV-2
infection has been proposed for adults, although this remains controversial. In children and …